NIEX LLC: Mongolia’s Next-generation Cryptocurrency Exchange “AIS-X” (Operated by: National Investment Exchange LLC) Had It's Grand Opening on September 30th, 2019 at 15:00 (GMT +8)
The token of our AIS-X exchange (https://ais-ex.com/) (Operated by NIEX LLC), the AIS token, was launched on BitForex’s IEO Turbo Launchpad on August 15th and sold out within only 6 minutes. Subsequently, it got listed on August 21st and just after a week its value rose by 10.0, which made it the number 1 in the ranking category of “increase in value”. (Over 8.0 as of October 25)
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191107006207/en/
GRAND OPEN (Graphic: Business Wire)
https://twitter.com/bitforexcom/status/1169092431196721152
AIS-X opened trade with a few BTC key pairs.
The schedule is as follows:
- 2019/10/29 18:00 (GMT+8) : BTC/TUSD Pair open
- 2019/11/5 18:00 (GMT+8) : ETH/TUSD & XRP/TUSD pairs open
AIS-X has partnered with KYC-Chain to improve its KYC authentication system.
SelfKey (a service offered by KYC-Chain) is a next-gen digital identity solution that allows users to store & manage identity documents, Ethereum, and ERC-20 tokens more securely than ever before.
Typically data is stored on servers that are vulnerable to hacks and data breaches. In contrast, SelfKey operates locally, meaning your data is stored on your device so even in the unlikely occasion that SelfKey’s servers are hacked, your data is unaffected.
Furthermore AIS-X has joined hands with TomoChain and generated its AIS token with the TRC21 standard. By using TomoChain, the users of AIS tokens can enjoy the benefits of the superior technology of TomoChain blockchain platform which provides high security, 2000 TPS, 2 sec block confirmation, and near-zero cost.
AIS-X puts the safety and convenience of the user first, which makes it special on the competitive cryptocurrency exchange market.
About AIS-X
While the core service of AIS-X is the cryptocurrency exchange, it also offers a comprehensive set of other services. For example, we plan to implement an AI concierge that will help the user to estimate price developments and make their own investment plans. (https://www.youtube.com/watch?v=ehin28Ngjns)
Also, the investors of AIS-X (AIS token holders) will not only profit from cryptocurrency earnings, but also from our investment in actual underground resources mining (e.g. metal).
- Exchange: https://ais-ex.com/
- Official website: https://ais-x.io/
Connect with us via SNS
- Official Telegram: https://t.me/aisofficial
- Official Twitter: https://twitter.com/aisx_official
- Official Facebook: https://www.facebook.com/AISXOFFICIAL
View source version on businesswire.com: https://www.businesswire.com/news/home/20191107006207/en/
Contact information
For inquiries regarding this press release
National Investment Exchange LLC (NIEX LLC)
Ryosuke Hagiwara
Address: 3rd Khoroo Usnii Street-1, Royal Plaza Building, Sukhbaatar, Ulaanbaatar, Mongolia
TEL: +81-90-8875-5597
Email: ais-support@ais-x.io
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF to Webcast Fireside Chat at Stifel Virtual Cross Sector Insight Conference June 82.6.2020 22:15:00 CEST | Press release
Regulatory News: IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent and nutrition, today announced that the Company’s management will be participating in a fireside chat at the Stifel Virtual Cross Sector Insight Conference on Monday, June 8, 2020 at 4:00 PM ET. Investors may access the live webcast on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), we’re using Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, we put science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products our world craves. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20200602005897/en/Contact information Micha
ZOOM International to Begin Doing Business As Elevēo2.6.2020 16:00:00 CEST | Press release
ZOOM International a worldwide leader in omni-channel compliance recording, workforce optimization (WFO), and revenue protection software for contact centers will begin doing business solely as elevēo beginning June 2nd, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005093/en/ For over 20 years, ZOOM International has been a leading workforce optimization software provider in the contact center industry. Very early on, we were approached to solve a compliance problem with call recording. We built a creative software solution in record time, and began a journey crossing continents, employing hundreds of colleagues, and eventually improving operations, compliance, and customer experience for thousands of customers in 94 countries via more than 550 channel partners in the communications industry. Over time we have earned an 88 NPS score from ZOOM International customers & partners for our world-class support and in
Dr Evidence (DRE), an AI-Enabled SaaS Healthcare Insights Company, Taps Industry Experts Joseph A. Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its Newly Formed Medical Strategy Advisory Board2.6.2020 16:00:00 CEST | Press release
DRE is pleased to welcome Joe Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its newly formed Medical Strategy Advisory Board (MSAB). These enhancements to the Company reflect the expanded need for keen guidance in this unprecedented time of convergence between expert AI-enabled technology in healthcare and the exponential growth of clinical information. DRE is dedicated to applying sophisticated data science with advanced AI to generate quicker, deeper, more nuanced regulatory-grade scientific and clinical insights for the betterment of patient outcomes. Boystak is an experienced healthcare venture capitalist and senior healthcare investment banker having been Founding Managing Partner at Health2047 Capital Partners and Founding Managing Director, Global Life Sciences at Jefferies. He is CEO of Brightwaters Capital and is a serial co-founder/investor in biomedical, med tech, health information technology, and artificial intelligence companies with spinouts fro
Andersen Global Expands Presence in Qatar2.6.2020 15:30:00 CEST | Press release
Andersen Global announced its collaboration with Doha-based tax firm MS Partner, adding depth to the organization’s presence in Qatar and expanding its global platform. MS Partner was founded in 2018 and includes two Partners and more than 10 professionals that specialize in providing tax services to a variety of international clients including individuals and companies – both private and public. MS Partner’s Chairman His Excellency Shaikh Sultan Bin Jassim Bin Mohammed Al Thani is a prominent business leader in the State of Qatar. “We value our clients and people, and maintain the highest of professional standards,” said Office Managing Director Manikandan Rajan. “We’ve watched Andersen Global grow regionally as well as globally, and the organization has set the standard for providing clients with best-in-class service in an independent and seamless manner. We look forward to working closely with our fellow collaborating firm in Doha, Al-Khalifa Law, as well as all the collaborating f
Pegasus Development AG: Pegasus Present Its New Brand Pegastril - Nuevo2.6.2020 15:06:00 CEST | Press release
The coronavirus pandemic harbours the potential for enormous growth in specific industries. To that end, however, it's important to identify which markets will be dominant in the future. One of the key growth sectors is the production and distribution of disinfectants and associated technologies. Regardless of whether a cure for, or vaccine against, COVID-19 is developed, protection against viruses and bacteria has become incredibly important across the globe and will continue to be a concern going forward. This was one of the reasons why Pegasus Development AG decided to partner with the British disinfectant manufacturer Nuevo. One of the decisive factors choosing Nuevo was its highly competitive product, which is free from alcohol, animal products, perfume, essential oils or dyes. Furthermore, the product has already been tested according to the highest stipulations of the European standard EN 1276, is manufactured according to the latest regulations of the European Biocides Directiv
PVH Corp. Announces Leadership Update at Tommy Hilfiger and PVH Europe2.6.2020 15:00:00 CEST | Press release
PVH Corp. (NYSE:PVH), owner of a portfolio of iconic brands including TOMMY HILFIGER and CALVIN KLEIN, announced today that Daniel Grieder is stepping down from his role of Chief Executive Officer, Tommy Hilfiger Global & PVH Europe after 23 years in various management roles within the organization, and will be leaving the company to pursue other interests. Martijn Hagman will succeed Grieder and become the new Chief Executive Officer, Tommy Hilfiger Global & PVH Europe, effective June 2, 2020. Hagman is currently Chief Operating Officer, Tommy Hilfiger Global & PVH Europe and Chief Financial Officer, Tommy Hilfiger Global, overseeing operations, finance, digital business transformation, technology, business development and the Tommy Hilfiger global sustainability program. He is a 12-year veteran of the Tommy Hilfiger leadership team and has been instrumental in Tommy Hilfiger’s impressive global expansion and the strategy that has led to PVH Europe’s consistent year-over-year growth.